James Huang1, Amy E Logue2, Jamie S Ostroff3, Bernard J Park4, Mary McCabe2, David R Jones4, Manjit S Bains4, Nabil P Rizk4, Mark G Kris5, Valerie W Rusch4. 1. Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: huangj@mskcc.org. 2. Memorial Sloan Kettering Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, New York. 3. Behavioral Sciences Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York. 4. Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. 5. Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract
BACKGROUND: Recent advances have improved the likelihood of long-term survival for patients with lung cancer. However, little attention has been given to the growing need for dedicated survivorship care for these patients. To address this unmet need, we developed a unique follow-up care model. METHODS: In 2006, we convened a multidisciplinary working group to design a thoracic survivorship program (TSP) that provides follow-up by a nurse practitioner (NP) trained in survivorship care. Patients with early-stage lung cancer who were disease free for at least 1 year after resection were eligible for the program, which incorporates a standardized approach to cancer surveillance. Data on symptoms and outcomes were prospectively collected. Real-time electronic medical documentation was developed to optimize communication with primary physicians. RESULTS: Data were analyzed for the initial phase of the program, which comprised 655 patients. Ninety-two percent of eligible survivors who remained disease free chose to continue their care in the TSP, rather than receive follow-up with their thoracic surgeon. Clinically significant posttreatment symptoms were common, including fatigue (46%), anxiety (32%), chronic pain (25%), dyspnea (14%), and depression (12%). The majority of recurrences (72%) and second primary cancers (91%) in this cohort were identified by scheduled chest computed tomography at TSP visits. CONCLUSIONS: Survivorship care for patients with lung cancer, delivered in our NP-led TSP, is feasible, effective, and well accepted by patients. Through the implementation of a uniform self-sustaining patient-centered system, the TSP model improves on the variation of physician-led follow-up care.
BACKGROUND: Recent advances have improved the likelihood of long-term survival for patients with lung cancer. However, little attention has been given to the growing need for dedicated survivorship care for these patients. To address this unmet need, we developed a unique follow-up care model. METHODS: In 2006, we convened a multidisciplinary working group to design a thoracic survivorship program (TSP) that provides follow-up by a nurse practitioner (NP) trained in survivorship care. Patients with early-stage lung cancer who were disease free for at least 1 year after resection were eligible for the program, which incorporates a standardized approach to cancer surveillance. Data on symptoms and outcomes were prospectively collected. Real-time electronic medical documentation was developed to optimize communication with primary physicians. RESULTS: Data were analyzed for the initial phase of the program, which comprised 655 patients. Ninety-two percent of eligible survivors who remained disease free chose to continue their care in the TSP, rather than receive follow-up with their thoracic surgeon. Clinically significant posttreatment symptoms were common, including fatigue (46%), anxiety (32%), chronic pain (25%), dyspnea (14%), and depression (12%). The majority of recurrences (72%) and second primary cancers (91%) in this cohort were identified by scheduled chest computed tomography at TSP visits. CONCLUSIONS: Survivorship care for patients with lung cancer, delivered in our NP-led TSP, is feasible, effective, and well accepted by patients. Through the implementation of a uniform self-sustaining patient-centered system, the TSP model improves on the variation of physician-led follow-up care.
Authors: David S Ettinger; Gerold Bepler; Raphael Bueno; Andrew Chang; Joe Y Chang; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Steven J Feigenberg; Frederic W Grannis; Thierry Jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Mark G Kris; Corey J Langer; Quynh-Thu Le; Renato Martins; Gregory A Otterson; Francisco Robert; David J Sugarbaker; Douglas E Wood Journal: J Natl Compr Canc Netw Date: 2006-07 Impact factor: 11.908
Authors: Marc B Feinstein; Paul Krebs; Elliot J Coups; Bernard J Park; Richard M Steingart; Jack Burkhalter; Amy Logue; Jamie S Ostroff Journal: J Thorac Oncol Date: 2010-08 Impact factor: 15.609
Authors: Jamie S Ostroff; Paul Krebs; Elliot J Coups; Jack E Burkhalter; Marc B Feinstein; Richard M Steingart; Amy E Logue; Bernard J Park Journal: Lung Cancer Date: 2010-05-11 Impact factor: 5.705
Authors: Melisa L Wong; Timothy L McMurry; George J Stukenborg; Amanda B Francescatti; Carla Amato-Martz; Jessica R Schumacher; George J Chang; Caprice C Greenberg; David P Winchester; Daniel P McKellar; Louise C Walter; Benjamin D Kozower Journal: Lung Cancer Date: 2016-11-09 Impact factor: 5.705
Authors: Hari B Keshava; Kay See Tan; Joe Dycoco; James Huang; Alison Berkowitz; Dyana Sumner; Amy Devigne; Prasad Adusumilli; Manjit Bains; Matthew Bott; James Isbell; Robert Downey; Daniela Molena; Bernard Park; Gaetano Rocco; Smita Sihag; David R Jones; Valerie W Rusch Journal: J Thorac Cardiovasc Surg Date: 2021-11-20 Impact factor: 6.439